ATE505465T1 - Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung - Google Patents

Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung

Info

Publication number
ATE505465T1
ATE505465T1 AT07076125T AT07076125T ATE505465T1 AT E505465 T1 ATE505465 T1 AT E505465T1 AT 07076125 T AT07076125 T AT 07076125T AT 07076125 T AT07076125 T AT 07076125T AT E505465 T1 ATE505465 T1 AT E505465T1
Authority
AT
Austria
Prior art keywords
thiochroman
dihydroimidazole
chroman
hydroxylase
inhibitors
Prior art date
Application number
AT07076125T
Other languages
English (en)
Inventor
David Alexander Learmonth
Da Silva Patricio Manuel Vieir Soares
Alexander Beliaev
Original Assignee
Bial Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa
Application granted granted Critical
Publication of ATE505465T1 publication Critical patent/ATE505465T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07076125T 2002-10-11 2003-10-10 Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung ATE505465T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0223719A GB2393958A (en) 2002-10-11 2002-10-11 Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
GB0224306A GB2394223B (en) 2002-10-11 2002-10-18 Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation

Publications (1)

Publication Number Publication Date
ATE505465T1 true ATE505465T1 (de) 2011-04-15

Family

ID=9945777

Family Applications (5)

Application Number Title Priority Date Filing Date
AT07076125T ATE505465T1 (de) 2002-10-11 2003-10-10 Chroman- und thiochroman-3-yl-1,3- dihydroimidazole als hemmer der dopamin-beta- hydroxylase und verfahren zu ihrer herstellung
AT07076122T ATE500248T1 (de) 2002-10-11 2003-10-10 Silyl-geschützte hydroxymethyl-carbamoylalkyl- ketone als intermediate in der herstellung von dopamine-beta-hydroxylase inhibitoren
AT03256420T ATE403652T1 (de) 2002-10-11 2003-10-10 Imidazolderivate und deren verwendung als peripheral-selektive inhibitoren von dopamin-beta-hydroxylasen
AT07076124T ATE500247T1 (de) 2002-10-11 2003-10-10 Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor
AT07076123T ATE550335T1 (de) 2002-10-11 2003-10-10 3,4-dihydro-3-amino-2h-1-benzopyran und - benzothiopyran derivate als dopamine-beta- hydroxylase inhibitoren und verfahren zu ihrer herstellung

Family Applications After (4)

Application Number Title Priority Date Filing Date
AT07076122T ATE500248T1 (de) 2002-10-11 2003-10-10 Silyl-geschützte hydroxymethyl-carbamoylalkyl- ketone als intermediate in der herstellung von dopamine-beta-hydroxylase inhibitoren
AT03256420T ATE403652T1 (de) 2002-10-11 2003-10-10 Imidazolderivate und deren verwendung als peripheral-selektive inhibitoren von dopamin-beta-hydroxylasen
AT07076124T ATE500247T1 (de) 2002-10-11 2003-10-10 Verfahren zur herstellung von 3-(1,3- dihydroimidazol-2-thion-1-yl)-chromanen und thiochromanen als dopamin-beta-hydroxylase inhibitor
AT07076123T ATE550335T1 (de) 2002-10-11 2003-10-10 3,4-dihydro-3-amino-2h-1-benzopyran und - benzothiopyran derivate als dopamine-beta- hydroxylase inhibitoren und verfahren zu ihrer herstellung

Country Status (11)

Country Link
KR (1) KR101350741B1 (de)
CN (1) CN100393715C (de)
AR (2) AR041589A1 (de)
AT (5) ATE505465T1 (de)
CY (2) CY1108452T1 (de)
DE (4) DE60336276D1 (de)
DK (2) DK1908760T3 (de)
ES (5) ES2384118T3 (de)
GB (2) GB2393958A (de)
HK (1) HK1116188A1 (de)
SI (2) SI1408038T1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
EP2655363B1 (de) * 2010-12-22 2017-04-12 Bial-Portela & CA, S.A. Kristalline formen und verfahren zu ihrer herstellung
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL82401A0 (en) * 1986-05-06 1987-11-30 Merrell Dow Pharma Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them
US4868210A (en) 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
CZ290082B6 (cs) * 1994-04-26 2002-05-15 Syntex (U. S. A.) Inc. Benzocykloalkylazolthionové deriváty, farmaceutický prostředek je obsahující, způsob jejich přípravy a meziprodukty přípravy

Also Published As

Publication number Publication date
GB2394223B (en) 2007-05-16
CY1108452T1 (el) 2014-04-09
AR095674A2 (es) 2015-11-04
DK1908760T3 (da) 2011-07-25
ES2384118T3 (es) 2012-06-29
DE60336276D1 (de) 2011-04-14
DE60336772D1 (de) 2011-05-26
DE60336275D1 (de) 2011-04-14
GB0224306D0 (en) 2002-11-27
CY1112457T1 (el) 2015-12-09
SI1908760T1 (sl) 2011-05-31
AR041589A1 (es) 2005-05-26
CN100393715C (zh) 2008-06-11
ATE500248T1 (de) 2011-03-15
KR20120038014A (ko) 2012-04-20
ATE550335T1 (de) 2012-04-15
DK1408038T3 (da) 2008-11-24
GB2394223A (en) 2004-04-21
HK1116188A1 (en) 2008-12-19
ATE403652T1 (de) 2008-08-15
ES2361939T3 (es) 2011-06-24
ATE500247T1 (de) 2011-03-15
GB2393958A (en) 2004-04-14
GB0223719D0 (en) 2002-11-20
KR101350741B1 (ko) 2014-01-10
CN1726211A (zh) 2006-01-25
SI1408038T1 (sl) 2008-10-31
ES2309279T3 (es) 2008-12-16
DE60322642D1 (de) 2008-09-18
ES2364919T3 (es) 2011-09-16
ES2361938T3 (es) 2011-06-24

Similar Documents

Publication Publication Date Title
DE60324376D1 (de) Halbleiterbauelement und Verfahren zu dessen Herstellung
DE60335802D1 (de) Fass und verfahren zu seiner herstellung
ATE554772T1 (de) Pteridine als hcv-hemmer und verfahren zu ihrer herstellung
DE602004021927D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
DE60325690D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
DE602006020386D1 (de) Duraimplantat und Verfahren zu seiner Herstellung
DE112005002085A5 (de) Zerspanungswerkzeug und Verfahren zu seiner Herstellung
DE60313602D1 (de) N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG
DE502004002403D1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE419260T1 (de) C-aryl-glucosid-sglt2-inhibitoren und verfahren zu ihrer herstellung
DE60334183D1 (de) Faserplatte und Verfahren zu ihrer Herstellung
DE60305105D1 (de) Aluminiumbeschichtetes Bauteil und Verfahren zu dessen Herstellung
ATE543896T1 (de) Granulat als zusatz zu reinigungsmittel und verfahren zu seiner herstellung
DE60337036D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
DE602004015020D1 (de) Harzverkapselter elektronischer Bauteil und Verfahren zu seiner Herstellung
DE602004002122D1 (de) Doppelrohr und Verfahren zu dessen Herstellung
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
DK1626964T3 (da) Nye benzimidazolderivater
DE60313797D1 (de) Halbleiter-Lichtemissionsbauelement und Verfahren zu seiner Herstellung
DE60335812D1 (de) Biosensor und verfahren zu seiner herstellung
DE60239493D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
ATE440821T1 (de) Isochinolinderivate als mao-b inhibitoren
ATE384069T1 (de) Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE60233077D1 (de) Halbleiterbauelement und verfahren zu seiner herstellung
DE60327412D1 (de) Kreisförmiger Metallgegenstand und Verfahren zu dessen Herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1908760

Country of ref document: EP